Asceneuron
Pre-clinicalAsceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases.
Founded
2012
Focus
Small Molecules
About
Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases.
Funding History
7Total raised: $393M
Venture$100MUndisclosedJul 16, 2024
Series C$100MMPM CapitalJan 15, 2022
Series C$60MMPM CapitalMar 15, 2021
Series B$58MMPM CapitalJan 15, 2019
Company Info
TypePrivate
Founded2012
LocationLausanne, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile